QTREX Quantum QTEX
NASDAQ QTEX
$1.41 -0.05 (-3.41%)
As of: Oct 21, 2026 · 11:40 AM EDT

QTREX Quantum (QTEX) Current Deferred Revenue (2024 - 2026)

Updated

QTREX Quantum (QTEX) posted Current Deferred Revenue of $196,000 for Q2 2026.

Analysis

QTREX Quantum (QTEX) Current Deferred Revenue (2024 - 2026) Analysis & Trends

At the end of FY2024, QTREX Quantum's Current Deferred Revenue came in at $1.61 million.

  • The Q2 2026 figure stands as the highest quarterly Current Deferred Revenue since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 260.30 Bn 239.33 Bn 4.88 Bn
2 Abbott Laboratories 170.90 Bn 141.33 Bn 7.27 Bn
3 Danaher 164.81 Bn 148.62 Bn 3.61 Bn
4 Intuitive Surgical 152.46 Bn 131.89 Bn 1.96 Bn
5 Medtronic 119.28 Bn 84.53 Bn 6.34 Bn
6 Stryker 112.91 Bn 99.03 Bn 4.50 Bn
7 Boston Scientific 64.87 Bn 59.63 Bn 3.85 Bn
8 Becton Dickinson 53.24 Bn 50.39 Bn 2.32 Bn
9 Edwards Lifesciences 50.42 Bn 34.43 Bn 1.35 Bn
10 QTREX Quantum 9.60 Mn -11.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Dec 31, 2024 1.61 Mn
API Access

QTREX Quantum Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=QTEX&period=max&api_key=YOUR_API_KEY